TENAYA THERAPEUTICS INC (TNYA)
US87990A1060 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to TNYA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.82. This target is 328.94% above the current price.
TNYA was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TNYA.
In the previous month the buy percentage consensus was at a similar level.
TNYA was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-21 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-03-20 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-30 | Leerink Partners | Initiate | Outperform |
| 2023-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-14 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-08-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-09 | Chardan Capital | Maintains | Buy |
| 2023-03-09 | HC Wainwright & Co. | Maintains | Buy |
| 2023-01-24 | Morgan Stanley | Maintains | Overweight |
| 2022-11-11 | Chardan Capital | Maintains | Buy |
| 2022-11-08 | Canaccord Genuity | Initiate | Buy |
| 2022-08-11 | Chardan Capital | Maintains | Buy |
| 2022-06-15 | HC Wainwright & Co. | Initiate | Buy |
| 2022-05-17 | Morgan Stanley | Maintains | Overweight |
| 2021-08-24 | Chardan Capital | Initiate | Buy |
| 2021-08-24 | Cowen & Co. | Initiate | Outperform |
| 2021-08-24 | Morgan Stanley | Initiate | Overweight |
| 2021-08-24 | Piper Sandler | Initiate | Overweight |